Gossamer Bio, Inc. (Nasdaq: GOSS), a biopharmaceutical company focused on the development and commercialization of ...
More than 80% of patients implanted with a transvenous phrenic nerve stimulation device for central sleep apnea had at least ...
Taking Tanzania as an example, this paper systematically analyzes the current situation and challenges of primary school ...
A new study found that a 12-week exercise program saw a significant improvement to the brain. There are plenty of clear ...
Eli Lilly scored $408 million in U.S. sales of eczema treatment Ebglyss in its first full year on the market in 2025. | With ...
The San Francisco Bay Conservation and Development Commission required the analysis when it approved a pilot project to ...
Gov. Josh Shapiro’s administration plans to move ahead with two multimillion-dollar projects to make it easier for disabled ...
A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in ...
A multi‑year equity study will examine whether the Richmond–San Rafael path stays or is repurposed for traffic.
A new study compared cushioned shoes and flat shoes for hip arthritis. Experts explain the surprising results—and how to ...
A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results